<DOC>
	<DOCNO>NCT02917863</DOCNO>
	<brief_summary>Thyroid disorder , particular hypothyroidism , associate gastrointestinal impairment , celiac disease . A study report increased prevalence celiac disease large cohort child affect congenital hypothyroidism , underlie relationship two condition . The hypothesis study onset celiac disorder may relate gut concentration thyroid hormone ( TH ) hypothyroidism patient treat replacement therapy . In fact , TH replacement therapy show low bioavailability consequent high gut concentration . Two different pharmaceutical formulation ( liquid solid , per o ) available . The liquid one good absorption profile bioavailability solid ; therefore , associate low TH intestinal concentration . According hypothesis , solid TH formulation could increase microbial diversity gut instead liquid form , due high local TH concentration . Based finding , purpose study evaluate effect two different pharmaceutical formulation TH gut term modification gut microbiota , inflammatory parameter gut absorption .</brief_summary>
	<brief_title>Randomized Crossover Trial Evaluation Possible Effects Intestine Two Different Pharmaceutical Forms L - Thyroxine Patients With Primary Acquired Hypothyroidism</brief_title>
	<detailed_description />
	<mesh_term>Hypothyroidism</mesh_term>
	<criteria>Children primary acquire hypothyroidism require Levothyroxine therapy ( na√Øve patient , &lt; 18 year ) Informed consent parent patient Age &lt; 3 year Patients secondary hypothyroidism , euthyroid sick syndrome thyroid hormone resistant Patients celiac disease , type I diabetes know autoimmune disease Patients genetic disease syndrome , Down , WilliamsBeuren , Turner Assumption antibiotic , probiotic , prebiotics , medication could affect gut microbiota month begin study Gastrointestinal infectious disease month begin study Hypersensitivity levothyroxine ingredient contain two pharmaceutical formulation Untreated adrenal insufficiency , untreated pituitary insufficiency untreated thyrotoxicosis . Patients cardiovascular disease Patients show impair pancreatic function measure use assay faecal fat ( steatocrit ) screen visit</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Hypothyroidism</keyword>
	<keyword>Microbiota</keyword>
	<keyword>Thyroid hormone</keyword>
	<keyword>L-Thyroxine</keyword>
	<keyword>Celiac disease</keyword>
</DOC>